Comparative effectiveness of bivalent BA. 4-5 and BA. 1 mRNA booster vaccines among adults aged≥ 50 years in Nordic countries: nationwide cohort study

NW Andersson, EM Thiesson, U Baum, N Pihlström… - bmj, 2023 - bmj.com
Objective To estimate the effectiveness of the bivalent mRNA booster vaccines containing
the original SARS-CoV-2 and omicron BA. 4-5 or BA. 1 subvariants as the fourth dose …

Understanding low COVID-19 booster uptake among US adults

ET Jacobs, FM Cordova-Marks, LV Farland, KC Ernst… - Vaccine, 2023 - Elsevier
Abstract Background Vaccinations against SARS-CoV-2 have consistently been shown to
reduce the risk of severe COVID-19 disease. However, uptake of boosters has stalled in the …

[HTML][HTML] Towards a post-pandemic future for global pathogen genome sequencing

JT Ladner, JW Sahl - PLoS Biology, 2023 - journals.plos.org
Pathogen genome sequencing has become a routine part of our response to active
outbreaks of infectious disease and should be an important part of our preparations for …

Efficacy of a bivalent (D614+ B. 1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind …

GH Dayan, N Rouphael, SR Walsh, A Chen… - The Lancet …, 2023 - thelancet.com
Background COVID-19 vaccines with alternative strain compositions are needed to provide
broad protection against newly emergent SARS-CoV-2 variants of concern. This study …

Antibody responses to Omicron BA. 4/BA. 5 bivalent mRNA vaccine booster shot

Q Wang, A Bowen, R Valdez, C Gherasim, A Gordon… - Biorxiv, 2022 - biorxiv.org
Abstract The SARS-CoV-2 Omicron variant and its numerous sub-lineages have exhibited a
striking ability to evade humoral immune responses induced by prior vaccination or …

A heterologous V-01 or variant-matched bivalent V-01D-351 booster following primary series of inactivated vaccine enhances the neutralizing capacity against SARS …

Z Zhang, Q He, W Zhao, Y Li, J Yang, Z Hu… - Journal of clinical …, 2022 - mdpi.com
Immune escape of emerging SARS-CoV-2 variants of concern (VOCs) and waning immunity
over time following the primary series suggest the importance and necessity of booster shot …

[HTML][HTML] T cell immune memory after covid-19 and vaccination

L Wang, A Nicols, L Turtle, A Richter, CJA Duncan… - BMJ …, 2023 - ncbi.nlm.nih.gov
The T cell memory response is a crucial component of adaptive immunity responsible for
limiting or preventing viral reinfection. T cell memory after infection with the SARS-CoV-2 …

School closures during COVID-19: an overview of systematic reviews

S Hume, SR Brown, KR Mahtani - BMJ Evidence-Based Medicine, 2023 - ebm.bmj.com
Objectives To assess the benefits and drawbacks of school closures and in-school
mitigations during the COVID-19 pandemic. Design Overview of systematic reviews (SRs) …

[HTML][HTML] Vacuna frente al COVID-19

JJ Picazo - Revista Española de Quimioterapia, 2021 - ncbi.nlm.nih.gov
La pandemia por COVID-19 ha producido en nuestra sociedad un colapso sanitario,
económico y psicológico enorme. Los sanitarios han tenido que enfrentarse a uno de los …

Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response

Y Qiao, JW Wotring, Y Zheng… - Proceedings of the …, 2023 - National Acad Sciences
Early in the COVID-19 pandemic, data suggested that males had a higher risk of developing
severe disease and that androgen deprivation therapy might be associated with protection …